Ascent Pharmaceuticals, Inc.
8Patents
0Active
8Granted
22Portfolio score
Filing activity: Jan 4, 1995 → Jun 28, 1996
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5672358A | Controlled release aqueous emulsion | Human Necessities | 31 | Expired |
| US5576346A | Process for treating uremic pruritus | Human Necessities | 21 | Expired |
| US5552436A | Process for treating hemangioma | Human Necessities | 16 | Expired |
| US5455049A | Terfenadine oral powder | Human Necessities | 9 | Expired |
| US5532270A | Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions | Human Necessities | 5 | Expired |
| US5626879A | Terfenadine oral granules | Human Necessities | 5 | Expired |
| US5684038A | Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions | Human Necessities | 0 | Expired |
| US5684037A | Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.